New Zealand markets open in 7 hours 32 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
176.92-3.36 (-1.86%)
At close: 04:00PM EST
177.00 +0.08 (+0.05%)
After hours: 05:12PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
-837,904
-858,281
-886,116
-761,497
-490,874
Depreciation & amortisation
46,578
34,772
17,175
6,435
13,367
Stock-based compensation
155,411
139,873
174,841
157,752
92,819
Change in working capital
-133,204
-12,701
402,381
45,099
-2,902
Accounts receivable
-63,516
-56,236
-24,238
15,242
-10,668
Inventory
-24,119
-35,426
-32,411
-22,645
-
Accounts payable
-
-
-
15,478
-4,939
Other working capital
-690,850
-685,322
-418,583
-689,503
-486,995
Other non-cash items
203,112
135,418
24,580
-6,841
2,910
Net cash provided by operating activities
-614,696
-614,961
-278,427
-562,616
-382,786
Cash flows from investing activities
Investments in property, plant and equipment
-76,154
-70,361
-140,156
-126,887
-104,209
Purchases of investments
-1,529,321
-2,025,626
-2,075,925
-1,104,046
-903,457
Sales/maturities of investments
1,673,055
1,691,669
1,775,404
1,518,703
597,305
Other investing activities
-25,363
-31,200
23,000
-14,825
120,000
Net cash used for investing activities
42,217
-435,518
-417,677
272,945
-290,361
Cash flows from financing activities
Debt repayment
-
0
-30,000
0
-120,000
Common stock issued
0
99,498
781,900
0
1,161,006
Common stock repurchased
-
-
-
-3,469
-257
Other financing activities
502,525
494,997
-
-
-
Net cash used provided by (used for) financing activities
1,172,777
994,979
823,184
65,470
1,124,891
Net change in cash
597,302
-50,582
126,997
-224,201
451,744
Cash at beginning of period
499,156
549,628
422,631
646,832
193,617
Cash at end of period
1,099,454
499,046
549,628
422,631
645,361
Free cash flow
Operating cash flow
-614,696
-614,961
-278,427
-562,616
-382,786
Capital expenditure
-76,154
-70,361
-140,156
-126,887
-104,209
Free cash flow
-690,850
-685,322
-418,583
-689,503
-486,995